Role of macrophages in the development of pancreatic islet injury in spontaneously diabetic torii rats

Experimental Animals

Volumn 58, Issue 4, 2009, Pages 383-394

  Inokuchi, Chie ^a   Ueda, Haruyasu ^a   Hamaguchi, Tomoya ^a   Miyagawa, Jun Ichiro ^a   Shinohara, Masami ^b   Okamura, Haruki ^a   Namba, Mitsuyoshi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b CLEA Japan Inc   (Japan)

Author keywords

Cl2MDP liposomes; IL 18; Monocytes macrophage; NO; SDT rat

Indexed keywords

CHLORDANE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; LIPOSOME; NITRATE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; BONE DENSITY CONSERVATION AGENT; CD68 PROTEIN, RAT; CLODRONIC ACID; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SPLEEN CELL; SPONTANEOUSLY DIABETIC TORII RAT; ANIMAL; BLOOD; CELL CULTURE; CELL SEPARATION; DISEASE MODEL; DRUG EFFECT; GENETICS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PATHOLOGY; SPLEEN; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE DENSITY CONSERVATION AGENTS; CELL COUNT; CELL SEPARATION; CELLS, CULTURED; CLODRONIC ACID; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-18; ISLETS OF LANGERHANS; LIPOSOMES; MACROPHAGES; MALE; MONOCYTES; NITRATES; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN;

EID: 73349105599     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.58.383     Document Type: Article

References (39)

1. Alves-Rosa, F., Stanganelli, C., Cabrera, J., van Rooijen, N., Palermo, M.S., and Isturiz, M.A. 2000. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 96: 2834-2840.
2. Arnush, M., Heitmeier, M.R., Scarim, A.L., Marino, M.H., Manning, P.T., and Corbett, J.A. 1998. IL-1 produced and released endogenously within human islets inhibits beta cell function. J. Clin. Invest. 102: 516-526.
3. Arnush, M., Scarim, A.L., Heitmeier, M.R., Kelly, C.B., and Corbett, J.A. 1998. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J. Immunol. 160: 2684-2691.
4. Chikano, S., Sawada, K., Shimoyama, T., Kashiwamura, S.I., Sugihara, A., Sekikawa, K., Terada, N., Nakanishi, K., and Okamura, H. 2000. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut 47: 779-786.
5. Corbett, J.A. and McDaniel, M.L. 1995. Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitoric oxide synthase. J. Exp. Med. 181: 559-568.
6. Corbett, J.A., Mikhael, A., Shimizu, J., Frederick, K., Misko, T.P., McDaniel, M.L., Kanagawa, O., and Unanue, E.R. 1993. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stage in the immunological diabetic process. Proc. Natl. Acad. Sci. U.S.A. 90: 8992-8995.
7. Danenberg, H.D., Fishbein, I., Gao, J., Monkkonen, J., Reich, R., Gati, I., Moerman, E., and Golomb, G. 2002. Macrophage depletion by clodronate-containing liposomes reduces neointimal after balloon injury in rats and rabbits. Circulation 106: 599-605.
8. Ford, E.S. 2002. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am. J. Epidemiol. 155: 57-64.
9. Gillessen, S., Carvajal, D., Ling, P., Podlaski, F.J., Stremlo, D.L., Familletti, P.C., Gubler, U., Presky, D.H., Stern, A.S., and Gately, M.K. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25: 200-206.
10. Gubler, U., Chua, A.O., Schoenhant, D.S., Dwyer, C.M., McComas, W., Motyka, R., Nabavi, N., Wolitzky, A.G., Quinn, P.M., Familletti, P.C., and Gately, M.K. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. U.S.A. 88: 4143-4147.
11. Heinzel, F.R., Rerko, R.M., Ling, P., Hakimi, J., and Schoenhaut, D.S. 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62: 4244-4249.
12. Hong, T.P., Andersen, N.A., Nielsen, K., Karlsen, A.E., Fantuzzi, G., Eizirik, D.L., Dinarello, C.A., and Mandrup-Poulsen, T. 2000. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutuvely expressed in islet bete-cells and up-regulated by interferon-gamma. Eur. Cytokine Netw. 11: 193-205.
13. Huitinga, I., van Rooijen, N., de Groot, C.J., Uitdehaag, B.M., and Dijkstra, C.D. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172: 1025-1033.
14. Jansen, A., Homo-Delarche, F., Hooikaas, H., Leenen, P.J., Derdenne, M., and Drexhage, H.A. 1994. Immunohistochemical characterization of monocytes-macrophages and dendrite cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 43: 667-675.
15. Jordan, M.B., van Rooijen, N., Izui, S., Kappler, J., and Marrack, P. 2003. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 101: 594-601.
16. Kroncke, K.D., Rodriguez, M.L., Kolb, H., and Kolb-Bachofen, V. 1993. Cytotoxicity of activated rat macrophages against sygeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside. Diabetologia 36: 17-24.
17. Lasbury, M.E., Durant, P.J., Ray, C.A., Tschang, D., Schwendener, R., and Lee, C.H. 2006. Suppression of alveolar macrophages apoptosis prolongs survival of rats and mice with Pneumocystis pneumonia. J. Immunol. 176: 6443-6453.
18. Laychock, S.G., Sessanna, S.M., Lin, M.H., and Mastrandrea, L.D. 2006. Sphingosine 1-phosphate affects cytokine-induced apoptpsis in rat pancreatic islet beta-cells. Endocrinology 147: 4705-4712.
19. Mandrup-poulsen, T., Helqvist, S., Wogensen, L.D., Molvig, J., Pociot, F., Johannesen, J., and Nerup, J. 1990. Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr. Top Microbiol. Immunol. 164: 169-193.
20. Masuyama, T., Komeda, K., Hara, A., Noda, M., Shinohara, M., Oikawa, T., Kanazawa, Y., and Taniguchi, K. 2004. Choronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. Biochem. Biophys. Res. Commun. 314: 870-877.
21. Nakanishi, N., Yoshida, H., Matsuo, Y., Suzuki, K., and Tatara, K. 2002. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 45: 42-48.
22. Nicoletti, F., Di Marco, R., Papaccio, G., Conget, I., Gomis, R., Bernardini, R., Sims, J.E., Shoenfeld, Y., and Bendtzen, K. 2003. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur. J. Immunol. 33: 2278-2286.
23. Oikawa, Y., Shimada, A., Kasuga, A., Morimoto, J., Osaki, T., Tatara, H., Miyazaki, T., Tashiro, F., Yamato, E., Miyazaki, J., and Saruta, T. 2003. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice. J. Immunol. 171: 5865-5875.
24. Podlaski, F.J., Nanduri, V.B., Hulmes, J.D., Pan, Y.C., Levin, W., Danho, W., Chizzonite, R., Gately, M.K., and Stern, A.S. 1992. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 294: 230-237.
25. Rabinovitch, A., Suarez-Pinzon, W.L., Sorensen, O., and Bleackley, R.C. 1996. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS-expressing cells and relationships to cytokines expressed in the islets. Endocrinology 137: 2093-2099.
26. Rabinovitch, A., Suarez-Pinzon, W.L., Sorensen, O., Bleackley, R.C., and Power, R.F. 1995. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154: 4874-4882.
27. Rodan, G. A. 1998. Mechanisms of action of bisphosphonates. Annu. Rev. Pharmacol. Toxicol. 38: 375-388.
28. Rosmalen, J.G., Matrin, T., Dobbs, C., Voerman, J.S., Drexhage, H.A., Haskina, K., and Leenen, P.J. 2000. Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes. Lab. Invest. 80: 23-30.
29. Selander, K.S., Monkkonen, J., Karhukorpi, E.K., Harkonen, P., Hannuniemi, R., and Vaananen, H.K. 1996. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophage. Mol. Pharmacol. 50: 1127-1138.
30. Shinohara, M., Masuyama, T., Shoda, T., Takahashi, T., Katsuda, Y., Komeda, K., Kuroki, M., Kakehashi, A., and Kanazawa, Y. 2000. A new spontaneously diabetic non-obese Torii rats strain with severe ocular complications. Int. J. Exp. diabetes Res. 1: 89-100.
31. Simpson, P.B., Mistry, M.S., Maki, R.A., Yang, W., Schwarz, D.A., Johnson, E.B., Lio, F.M., and Alleva, D.G. 2003. Cutting edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice. J. Immunol. 171: 3333-3337.
32. Steer, S.A., Maran, J.M., Christmann, B.S., Maggi, L.B. Jr., and Corbett, J.A. 2006. Role of MAPK in the regulation of double-stranded RNA-and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages. J. Immunol. 177: 3413-3420.
33. Steer, S.A., Scarim, A.L., Chamber, K.T., and Corbett, J.A. 2006. Interleukin-1 stimulates beta-cell necrosis and release of the immunoligocal adjuvant HMGB1. PLoS Med. 3: e17.
34. Thorand, B., Kolb, H., Baumert, J., Koenig, W., Chambless, L., Meisinger, C., Illig, T., Martin, S., and Herder, C. 2005. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 54: 2932-2938.
35. Tsuji-Takayama, K., Aizawa, Y., Okamoto, I., Kojima, H., Koide, K., Takeuchi, M., Ikegami, H., Ohta, T., and Kurimoto, M. 1999. Interleukin-18 induced interferon-gamma production through NF-kappaB and NFAT activation in murine T helper type 1 cells. Cell Immunol. 196: 41-50.
36. Unanue, E., Byersdorfer, C., Carrero, J., Levisetti, M., Lovitch, S., Pu, Z., and Suri, A. 2005. Antigen presentation: lysolyme, autoimmune diabetes, and Listeria-what do they have in common? Immunol. Res. 32: 267-292.
37. van Rooijen, N. and Sanders, A. 1994. Liposomes mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
38. van Rooijen, N. and van Nieuwmegen, R. 1984. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsuletes dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res. 238: 355-358.
39. Zaccone, P., Phillips, J., Conget, I., Cooke, A., and Nicoletti, F. 2005. IL-18 binding protein fusion construnt delay the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin. Immunol. 115: 74-79.